These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25515506)

  • 41. Role of bioactivation in drug-induced hypersensitivity reactions.
    Sanderson JP; Naisbitt DJ; Park BK
    AAPS J; 2006 Feb; 8(1):E55-64. PubMed ID: 16584134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug metabolites in safety testing.
    Hastings KL; El-Hage J; Jacobs A; Leighton J; Morse D; Osterberg RE
    Toxicol Appl Pharmacol; 2003 Jul; 190(1):91-2;author reply 93-4. PubMed ID: 12831788
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug-induced hepatotoxicity.
    Lee WM
    N Engl J Med; 1995 Oct; 333(17):1118-27. PubMed ID: 7565951
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hepatic cytoprotection (3). Mechanisms of protection against the hepatotoxicity of drugs].
    Larrey D
    Gastroenterol Clin Biol; 1989 Jun; 13(6-7):572-6. PubMed ID: 2666245
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of active metabolites in drug toxicity.
    Pirmohamed M; Kitteringham NR; Park BK
    Drug Saf; 1994 Aug; 11(2):114-44. PubMed ID: 7945999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of reactive drug metabolites in immune-mediated adverse drug reactions.
    Hess DA; Rieder MJ
    Ann Pharmacother; 1997 Nov; 31(11):1378-87. PubMed ID: 9391694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hepatitis caused by drugs. I].
    Valerdiz Casasola S; Linares Rodríguez A; Recarte Alvarez J; Rodrigo Sáez L
    Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):74-82. PubMed ID: 6753061
    [No Abstract]   [Full Text] [Related]  

  • 48. The liver: a pharmacologic perspective.
    Bossone CM
    Nurs Clin North Am; 1977 Jun; 12(2):291-303. PubMed ID: 585856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-induced liver disease: pathogenetic mechanisms and histopathological lesions.
    Desmet VJ
    Eur J Med; 1993 Jan; 2(1):36-47. PubMed ID: 8258005
    [No Abstract]   [Full Text] [Related]  

  • 50. In silico predictions of ADME/T properties: progress and challenge.
    Hou T
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):306. PubMed ID: 21470177
    [No Abstract]   [Full Text] [Related]  

  • 51. Metabolic activation: biochemical basis for many drug-induced liver injuries.
    Mitchell JR; Nelson SD; Thorgeirsson SS; McMurtry RJ; Dybing E
    Prog Liver Dis; 1976; 5():259-79. PubMed ID: 775543
    [No Abstract]   [Full Text] [Related]  

  • 52. Ask the experts: computational chemistry.
    Matta CF; Hutter MC
    Future Med Chem; 2018 Jul; 10(13):1521-1524. PubMed ID: 29992825
    [No Abstract]   [Full Text] [Related]  

  • 53. A comprehensive listing of bioactivation pathways of organic functional groups.
    Kalgutkar AS; Gardner I; Obach RS; Shaffer CL; Callegari E; Henne KR; Mutlib AE; Dalvie DK; Lee JS; Nakai Y; O'Donnell JP; Boer J; Harriman SP
    Curr Drug Metab; 2005 Jun; 6(3):161-225. PubMed ID: 15975040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting drug side-effects by chemical systems biology.
    Tatonetti NP; Liu T; Altman RB
    Genome Biol; 2009; 10(9):238. PubMed ID: 19723347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology.
    Erve JC
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):923-46. PubMed ID: 17125409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical basis for dose response relationships in reactive metabolite toxicity.
    Jollow DJ; Roberts S; Price V; Smith C
    Adv Exp Med Biol; 1981; 136 Pt A():99-113. PubMed ID: 7344497
    [No Abstract]   [Full Text] [Related]  

  • 57. Failed Pediatric Drug Development Trials.
    Momper JD; Mulugeta Y; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):245-51. PubMed ID: 25963725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic activation in drug allergies.
    Park BK; Naisbitt DJ; Gordon SF; Kitteringham NR; Pirmohamed M
    Toxicology; 2001 Feb; 158(1-2):11-23. PubMed ID: 11164988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-induced liver injury.
    van Berge Henegouwen GP; Vogten AJ
    Neth J Med; 1980; 23(1):23-32. PubMed ID: 6988728
    [No Abstract]   [Full Text] [Related]  

  • 60. Minimizing the risk of chemically reactive metabolite formation of new drug candidates: implications for preclinical drug design.
    Brink A; Pähler A; Funk C; Schuler F; Schadt S
    Drug Discov Today; 2017 May; 22(5):751-756. PubMed ID: 27903430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.